Paula Alonso-Gonzalez

Madrid, MD 28040, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

The Hippo Pathway Transducers YAP1/TEAD Induce Acquired Resistance to Trastuzumab in HER2-Positive Breast Cancer.

The Hippo Pathway Transducers YAP1/TEAD Induce Acquired Resistance to Trastuzumab in HER2-Positive Breast Cancer.

Journal: Cancers

Published: March 30, 2020

Autocrine CCL5 Effect Mediates Trastuzumab Resistance by ERK Pathway Activation in HER2-Positive Breast Cancer.

Autocrine CCL5 Effect Mediates Trastuzumab Resistance by ERK Pathway Activation in HER2-Positive Breast Cancer.

Journal: Molecular cancer therapeutics

Published: December 30, 2019

Molecular evidence of field cancerization initiated by diabetes in colon cancer patients.

Molecular evidence of field cancerization initiated by diabetes in colon cancer patients.

Journal: Molecular oncology

Published: September 06, 2018

Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast Cancer.

Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 10, 2017

Generation, characterization, and maintenance of trastuzumab-resistant HER2+ breast cancer cell lines.

Generation, characterization, and maintenance of trastuzumab-resistant HER2+ breast cancer cell lines.

Journal: American journal of cancer research

Published: September 16, 2016

The role of miR-26a and miR-30b in HER2+ breast cancer trastuzumab resistance and regulation of the CCNE2 gene.

The role of miR-26a and miR-30b in HER2+ breast cancer trastuzumab resistance and regulation of the CCNE2 gene.

Journal: Scientific reports

Published: August 12, 2016

Recent Insights into the Development of Preclinical Trastuzumab- Resistant HER2+ Breast Cancer Models.

Recent Insights into the Development of Preclinical Trastuzumab- Resistant HER2+ Breast Cancer Models.

Journal: Current medicinal chemistry

Published: May 24, 2016

MicroRNA-31 Emerges as a Predictive Biomarker of Pathological Response and Outcome in Locally Advanced Rectal Cancer.

MicroRNA-31 Emerges as a Predictive Biomarker of Pathological Response and Outcome in Locally Advanced Rectal Cancer.

Journal: International journal of molecular sciences

Published: April 22, 2016

Potential anti-tumor effects of FTY720 associated with PP2A activation: a brief review.

Potential anti-tumor effects of FTY720 associated with PP2A activation: a brief review.

Journal: Current medical research and opinion

Published: March 08, 2016

c-Jun N-Terminal Kinase Inactivation by Mitogen-Activated Protein Kinase Phosphatase 1 Determines Resistance to Taxanes and Anthracyclines in Breast Cancer.

c-Jun N-Terminal Kinase Inactivation by Mitogen-Activated Protein Kinase Phosphatase 1 Determines Resistance to Taxanes and Anthracyclines in Breast Cancer.

Journal: Molecular cancer therapeutics

Published: November 16, 2015

Downregulation of microRNA-199b predicts unfavorable prognosis and emerges as a novel therapeutic target which contributes to PP2A inhibition in metastatic colorectal cancer.

Downregulation of microRNA-199b predicts unfavorable prognosis and emerges as a novel therapeutic target which contributes to PP2A inhibition in metastatic colorectal cancer.

Journal: Oncotarget

Published: November 02, 2015

Downregulation of miR-138 as a Contributing Mechanism to Lcn-2 Overexpression in Colorectal Cancer with Liver Metastasis.

Downregulation of miR-138 as a Contributing Mechanism to Lcn-2 Overexpression in Colorectal Cancer with Liver Metastasis.

Journal: World journal of surgery

Published: August 29, 2015

Showing 1-12 of 18

Last Updated: 09/26/2026